Curis Inc financial data

Symbol
CRIS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
128 Spring Street, Building C, Suite 500, Lexington, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 515 % -41.8%
Debt-to-equity 269 % +113%
Return On Equity -225 % -117%
Return On Assets -60.9 % -32.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.89 M shares -93.9%
Common Stock, Shares, Outstanding 5.89 M shares -93.9%
Entity Public Float 82.3 M USD -8.25%
Common Stock, Value, Issued 59 K USD -93.9%
Weighted Average Number of Shares Outstanding, Basic 5.78 M shares +19.7%
Weighted Average Number of Shares Outstanding, Diluted 5.78 M shares +19.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.81 M USD -5.67%
General and Administrative Expense 18.8 M USD +0.23%
Costs and Expenses 59 M USD -1.55%
Operating Income (Loss) -49.2 M USD +0.69%
Nonoperating Income (Expense) 1.44 M USD +772%
Net Income (Loss) Attributable to Parent -47.7 M USD +8.43%
Earnings Per Share, Basic -8.62 USD/shares +39.9%
Earnings Per Share, Diluted -8.62 USD/shares +39.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30 M USD -5.49%
Marketable Securities, Current 10.8 M USD -73.1%
Cash, Cash Equivalents, and Short-term Investments 40.7 M USD -43.3%
Accounts Receivable, after Allowance for Credit Loss, Current 2.15 M USD -6.91%
Assets, Current 46.1 M USD -40.9%
Property, Plant and Equipment, Net 370 K USD -40.8%
Operating Lease, Right-of-Use Asset 2.7 M USD -33.7%
Goodwill 8.98 M USD 0%
Assets 62 M USD -34.4%
Accounts Payable, Current 3.63 M USD +37.3%
Employee-related Liabilities, Current 1.53 M USD +2.54%
Accrued Liabilities, Current 6.33 M USD +49%
Liabilities, Current 11.3 M USD +40.1%
Operating Lease, Liability, Noncurrent 1.14 M USD -54.4%
Liabilities 52.6 M USD -9.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 338 K USD +3656%
Retained Earnings (Accumulated Deficit) -1.21 B USD -4.11%
Stockholders' Equity Attributable to Parent 9.46 M USD -74.1%
Liabilities and Equity 62 M USD -34.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.2 M USD -8.47%
Net Cash Provided by (Used in) Financing Activities -2.41 M USD -19.9%
Net Cash Provided by (Used in) Investing Activities 18.9 M USD -27.9%
Common Stock, Shares Authorized 22.8 M shares -90%
Common Stock, Shares, Issued 5.89 M shares -93.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.28 M USD -72.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.5 M USD -5.66%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 198 M USD +7.29%
Deferred Tax Assets, Gross 199 M USD +7.05%
Operating Lease, Liability 2.5 M USD -32.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -47.4 M USD +8.25%
Lessee, Operating Lease, Liability, to be Paid 3.07 M USD -32.5%
Property, Plant and Equipment, Gross 2.43 M USD -22.9%
Operating Lease, Liability, Current 1.35 M USD +14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.56 M USD +2.84%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.51 M USD +2.79%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 276 K USD -54.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.56 M USD +28.7%
Deferred Tax Assets, Operating Loss Carryforwards 91 M USD +14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 1.5 M USD -37.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 836 K USD -30.2%
Share-based Payment Arrangement, Expense 6.16 M USD -4.12%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares